Mailed FIT Outreach 2022

NCT05341622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5460

Last updated 2024-07-24

Study results available
· View outcomes & findings →

Summary

This project aims to evaluate different approaches to increase colorectal cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase response rate to mailed fecal immunochemical test (FIT) kits among eligible patients, including differentiated packaging, sending text reminders, and personalized reminders.

Conditions

Interventions

BEHAVIORAL

Differentiated Box

Patients will receive mailed FIT kits in a box with differentiated packaging

BEHAVIORAL

Standard Mail

Patients will receive mailed FIT in a standard mailing envelope

BEHAVIORAL

Text

Patients will receive a series of up to 3 texts explaining the importance of colon cancer screening and prompts to complete the mailed FIT.

BEHAVIORAL

No Text

Patients will not receive text messaging explaining the importance of colon cancer screening or prompts to complete the mailed FIT.

BEHAVIORAL

Reminder

Patients will receive a mailed letter reminder to complete their FIT kit if not resulted by 1 month from initial outreach.

BEHAVIORAL

No Reminder

Patients will not receive any mailed letter reminder to complete their FIT kit.

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Shivan Mehta, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-27
Primary Completion
2022-10-13
Completion
2022-12-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05341622 on ClinicalTrials.gov